obecabtagene autoleucel
autolus
['felix', 'leusm']
the car t-cell therapy obecabtagene autoleucel produced an orr of 76% in adults with rel/ref b-all in the phase 2 felix study. #asco23 #allsm #leusm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.